Enable Injections Enhances Board with Addition of Three New Directors
prnewswire.com
business
2022-06-02 14:20:00

Jim Collins brings over two decades of expertise as a global biopharma executive, most recently at Sanofi and Eli Lilly, in device research and development, design, packaging and delivery. Jim dedicated his career to developing and launching multiple innovative drug delivery technologies to improve patient convenience. These included the market-leading insulin KwikPen Platform, the Trulicity Pen Platform, the Talz Pen Platform, the Savvio Pen, the Forteo Pen, and a number of other first-to-market delivery systems.
